Manuel Ramos-Casals Selected Research

Manuel Ramos-Casals Research Topics

Disease

21	Infections 01/2022 - 08/2002
20	Vasculitis (Vasculitides) 01/2022 - 03/2004
19	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2003
18	Neoplasms (Cancer) 01/2024 - 08/2003
16	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2006
12	Cryoglobulinemia 01/2022 - 08/2003
10	Sarcoidosis (Schaumann Disease) 11/2021 - 03/2004
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2011 - 03/2004
5	Dry Eye Syndromes (Dry Eye Syndrome) 11/2023 - 03/2007
5	COVID-19 12/2022 - 01/2021
5	Cytopenia 01/2022 - 03/2003
5	Arthritis (Polyarthritis) 05/2021 - 03/2004
5	Virus Diseases (Viral Diseases) 04/2021 - 08/2006
5	Fatigue 01/2021 - 07/2010
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 01/2004
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2010 - 04/2006
4	Lymphoma (Lymphomas) 01/2022 - 07/2008
4	Anemia 01/2022 - 02/2004
4	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2003
4	Uveitis 01/2021 - 03/2004
4	Lupus Nephritis 01/2016 - 06/2011
4	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 07/2015 - 04/2010
4	Leukopenia 01/2015 - 07/2008
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2011 - 07/2007
4	Rheumatoid Arthritis 10/2011 - 07/2005
4	Vascular Skin Diseases 02/2007 - 04/2002
3	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 02/2007
3	Fever (Fevers) 01/2021 - 12/2006
3	Hypertension (High Blood Pressure) 01/2019 - 09/2003
3	Chronic Hepatitis C 04/2017 - 03/2003
3	Lung Diseases (Lung Disease) 01/2015 - 03/2005
3	Liver Diseases (Liver Disease) 12/2013 - 08/2006
3	Renal Insufficiency (Renal Failure) 03/2012 - 11/2008
2	Sialadenitis 12/2022 - 03/2004
2	Granuloma 12/2022 - 05/2011
2	Autoimmune Hepatitis 12/2021 - 01/2010
2	Lymphopenia (Lymphocytopenia) 01/2021 - 05/2018
2	Inflammation (Inflammations) 01/2021 - 05/2015
2	Pain (Aches) 01/2019 - 09/2014
2	Immunoglobulin G4-Related Disease 06/2016 - 07/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2016 - 11/2008
2	Fibrosis (Cirrhosis) 05/2015 - 03/2003
2	Sjogren's Syndrome (Sjogren Syndrome) 09/2014 - 02/2013
2	Arthralgia (Joint Pain) 02/2013 - 07/2010
2	Disease Progression 01/2013 - 07/2003
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2012 - 11/2008
2	Microscopic Polyangiitis 07/2012 - 04/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2011 - 05/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2008 - 02/2004
2	Raynaud Disease (Raynaud's Disease) 07/2008 - 03/2004
2	Thyroiditis 07/2008 - 05/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2005 - 08/2003

Drug/Important Bio-Agent (IBA)

18	AntibodiesIBA 12/2022 - 04/2002
17	CryoglobulinsIBA 01/2022 - 03/2003
14	AutoantibodiesIBA 01/2022 - 08/2002
14	Rituximab (Mabthera)FDA Link 01/2016 - 01/2004
12	Rheumatoid FactorIBA 05/2018 - 03/2004
10	GlucocorticoidsIBA 01/2022 - 07/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011 - 07/2005
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2005
8	Antinuclear AntibodiesIBA 01/2019 - 04/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 03/2003
7	Etanercept (Enbrel)FDA Link 02/2015 - 07/2007
6	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2019
6	Infliximab (Remicade)FDA Link 11/2011 - 07/2007
5	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 09/2003
5	Immunoglobulin G (IgG)IBA 04/2017 - 02/2004
4	Monoclonal AntibodiesIBA 01/2024 - 03/2011
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 02/2013
4	CytokinesIBA 05/2021 - 08/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 03/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2013 - 03/2005
3	SS-A antibodiesIBA 12/2022 - 03/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 02/2004
3	Immunoglobulin M (IgM)IBA 04/2017 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 02/2004
3	Adalimumab (Humira)FDA Link 07/2011 - 07/2007
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 05/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 11/2008
2	AutoantigensIBA 04/2021 - 05/2015
2	SteroidsIBA 01/2021 - 09/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2017 - 01/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 07/2005
2	Immunoglobulin E (IgE)IBA 07/2015 - 06/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2012 - 02/2007
2	Pilocarpine (Ocusert)FDA LinkGeneric 07/2010 - 03/2007
2	cevimeline (Evoxac)FDA Link 07/2010 - 03/2007
2	Complement System Proteins (Complement)IBA 04/2010 - 02/2004
2	Interferon-alpha (Interferon Alfa)IBA 03/2005 - 03/2003

Therapy/Procedure

38	Therapeutics 01/2022 - 03/2003
8	Biological Therapy 12/2016 - 11/2008
7	Immunotherapy 12/2022 - 01/2018
3	Off-Label Use 01/2016 - 11/2008
2	Immunomodulation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2016
2	Aftercare (After-Treatment) 06/2016 - 03/2005